26 March 2024 in Tuberk Toraks
Flexible bronchoscopy is a valuable method in the diagnosis and treatment of respiratory tract diseases in children. This study aimed to examine the indications for and results of flexible bronchoscopy in children. The study included patients aged 0-18 years who underwent flexible bronchoscopy between 1 January 2017 and 31 December 2022. The patients were evaluated for demographic characteristics, indications for bronchoscopy, comorbidities, bronchoscopy findings, and the results of bronchoalveolar lavage. During the defined study period, a total of 410 flexible bronchoscopy procedures were performed. 51.9% of the patient population were male, and 48.1% were female, with a mean age of 96.93 ± 63.45 months. The most common indication for flexible bronchoscopy was recurrent lower respiratory tract infection (26.8%), followed by chronic cough (19.1%). The bronchoalveolar lavage culture results showed that the most commonly isolated microorganisms were H. influenzae non-type b (7.8%) followed by M. catarrhalis (7.3%). Mucus obstruction and secretion (33.0%) constituted the most common bronchoscopic findings, while the flexible bronchoscopy examination was normal in 27% of patients. No serious complications occurred in any patient during or after the procedure. The results of this study demonstrated that the most common indication for flexible bronchoscopy was recurrent lower respiratory tract infection and the most common bronchoscopy finding was purulent secretion with mucus obstruction. Flexible bronchoscopy is an important diagnostic and treatment tool for patients with recurrent respiratory symptoms. It is a highly valuable method as it enables direct visualization of the airways and facilitates the collection of bronchoalveolar lavage samples.
16 July 2025 in European Journal of Pediatrics
22 September 2025 in Pediatric Allergy and Immunology
25 May 2026 in Indian Journal of Pediatrics
22 November 2024 in Balkan Medical Journal
Since January 2015, the Cystic Fibrosis National Newborn Bloodspot Screening (CF-NBS) program has been implemented in Turkey with two samples of immune reactive trypsinogen (IRT-1/IRT-2) testing. This study aimed to evaluate the Turkish national CF screening program, which included patients referred to a tertiary pediatric pulmonology center, to ascertain the optimal cut-off values for IRT-1/IRT-2 and to identify alternative strategies for mitigating the number of late-diagnosed false-negative patients (FNPs) who initially exhibited screen negative results but were diagnosed subsequently based on clinical suspicion. The study also compared NBS-positive patients to FNPs to determine the influence of delayed diagnosis. A retrospective cohort study. Screening for CF was conducted in accordance with the national CF-NBS program within 48-72 hours of birth by collecting a few drops of heel blood on Guthrie paper. A cut-off value of 90 μg/l was accepted for the first IRT, while 70 μg/l was accepted for the second sample. Infants with elevated IRT values in both samples were referred to the CF centers for a sweat test (ST). Based on the diagnosis, the NBS-positive infants referred to our CF center for ST analysis were divided into three groups: CF; cystic fibrosis-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID); and false-positive NBS. In addition, the study included NBS-negative patients who initially received negative screen results but were subsequently diagnosed with CF based on clinical suspicion. Of the 227 NBS-positive infants referred within the study period, 53 (23.34%) were diagnosed with CF (true-positive NBS), 11 were classified as CRMS/CFSPID (4.84%), and 163 were classified as falsepositive NBS (71.8%). CF was diagnosed in 66 infants, 53 (80.3%) of whom were confirmed using the NBS test, while the 13 (19.7%) patients who were missed on the NBS test were diagnosed based on clinical suspicion (FNP). The study findings indicate that the IRT/IRT approach exhibited a sensitivity of 80.3% and a positive predictive value (PPV) of 23.3%. The current study is the first to analyze the NBS program for CF using data from the Western Anatolian Region of Türkiye. Due to the low sensitivity and PPV of the IRT/IRT protocol and the high proportion of false-positive infants and FNPs, the current national program is not practicable for Türkiye. False-negative results significantly delay the diagnosis and invalidate the screening objectives. It is essential to establish optimal cut-off values for IRT-1/IRT-2 or revise existing strategies to reduce the number of FNPs missed by the screening program.
22 September 2025 in Tuberk Toraks
Pulmonary atelectasis is a significant respiratory problem in children. This study aimed to investigate the underlying causes of atelectasis and evaluate the outcomes of flexible fiberoptic bronchoscopy (FFB) in pediatric patients with this condition. Clinical data and outcomes of 110 children who underwent FFB were retrospectively analyzed based on radiological imaging obtained at three and six months following the procedure, and the patients were categorized into three groups: Group 1 (complete resolution of atelectasis), Group 2 (partial resolution), and Group 3 (no resolution). Between January 2016 and December 2023, a total of 110 pediatric patients with pulmonary atelectasis underwent FFB. The most common bronchoscopic findings were mucus plugs and secretions (50%), foreign body aspiration (7.3%), and congenital airway anomalies (3.6%). In 30% of the patients, bronchoscopy findings were normal. Complete resolution of atelectasis was observed in 55.4% of patients following FFB. The median duration of atelectasis in Group 3 was 90 days, significantly longer than that found in the other two groups (p= 0.002). Additionally, the median hospitalization period prior to bronchoscopy in Group 3 was 21 days, which was also longer than that found in the other groups (p= 0.004). The median atelectasis score in Group 1 was 2.34 (range: 0.9-3.1), significantly lower than in Groups 2 and 3 (p= 0.005). FFB is an effective tool for identifying the etiology of atelectasis in children. Prolonged duration of atelectasis and the presence of comorbidities were identified as risk factors for persistent, non-resolving atelectasis.